EMCDDA Home
  • EN
Search

Tips: Click on a column heading to order the results.Use the filters to limit the number of results.

More help>>

Displaying results 1–10 of 15 where Substances addressed by the intervention is Tobacco

<< previous next >>

Filter results:

Project description Intervention type Evaluation type Setting Target group Country Quality level
Title: Be Smart -Don't Start (Smokefree Class Competition)
Summary: The main aim of the programme is to delay the onset of smoking in pupils who do not smoke and the cessation of smoking in pupils already experimenting. >>
prevention outcome evaluation, process evaluation school children/young people Germany 3
Title: Programme for the Prevention of Tobacco Addiction at Secondary Schools
Summary: The programme intends to reduce the number of students experimenting with tobacco for the first time. >>
prevention outcome evaluation school children/young people Spain 2
Title: Quit and Win: A Community Intervention Programme to Quit Smoking
Summary: The programme is directed at smokers over 18 years of age who have been smoking regularly for more than one year. It is the Spanish version of the international 'Quit and Win' programme promoted by the World Health Organisation. >>
prevention outcome evaluation community adults Spain 1
Title: Treatment of Tobacco Dependency Among Hospital Patients
Summary: The project developed a system for advising and treating patients with tobacco dependency, based on the national Current Care guideline on smoking, nicotine dependency and withdrawal treatment. The system was implemented in health care facilities (specialised health care, primary health care, other hospital districts) in Finland. The project produced a treatment system for patients with tobacco dependency that provides guidelines for individual- and group-level guidance. >>
treatment outcome evaluation, process evaluation adults Finland 1
Title: Smoking cessation treatment and reimbursement
Summary: A randomised clinical trial that aimed to investigate whether smoking cessation treatment for which the treatment costs are reimbursed is more effective than treatment for which no costs are reimbursed. >>
treatment outcome evaluation general population Netherlands 2
Title: Do you smoke or do you live?
Summary: The hands-on course 'DO YOU SMOKE OR DO YOU LIVE' is a modern method of tobacco prevention, based on experiential education and targeted at young people. Sensual experience, information and competition are combined and prove to enable significant knowledge transfer. In addition, a positive image of non-smokers is promoted. >>
prevention outcome evaluation school, community children/young people Germany 2
Title: Efficacy of a Smoking Cessation Programme in a Smoking Cessation Service
Summary: The programme can be provided as individual and group. The individual treatment programme consists of 10 consultations; the first is the baseline and the remaining 9 are the follow-up. The baseline consultation lasts between 30 and 40 min, and at the end patients choose Quit-date. During this visit, which is always given by an Specialist on Smoking Treatment, the clinical and smoking history is taken, and various tests are performed: measurement of CO in expired air, spirometry and measurement of cotinine levels in body fluids. The follow-up visits are held at 1st, 2nd, 4th, 8th, 10th and 12th weeks, then 4th, 6th and 12th months after quit-date, and are all independently conducted by Healthcare Professionals Specialist on Smoking Treatment. These consultations are to control withdrawal symptoms, provide cognitive behavioural treatment and prescribe drug therapy. Different tests are also performed, e.g. measurement of CO in expired air and measurement of cotinine levels in body fluids. Three times a week, the patients’ situation is considered in a clinical session held by all members of the Smoking Cessation Service, where each case is discussed and appropriate decisions are taken. The group treatment programme consists of 9 sessions. The first takes place a few days before quit-date and lasts approximately 80-90 min. During this session, the patients choose their quit-date and receive advice in preparing for it. They are then informed about the basics of withdrawal. In addition, various tests are performed: measurement of CO in expired air, spirometry and measurement of cotinine levels in body fluids. The remaining sessions are held at 1st, 2nd, 4th, 8th, 10th, and 12th weeks, then at 4th and 5th months after quit-date. These sessions help to control withdrawal and prescribe drug therapy, as well as explain the different cognitive behavioural techniques to patients. Various tests are also performed: measurement of CO in expired air and measurement of cotinine levels in body fluids. The prescribed treatment is a combination of pharmacological and psychological treatment. The drug therapy consists of the different types of Nicotine Replacement Therapy used in Spain, bupropion or varenicline, or a combination of both. The psychotherapy consists of the following activities: self-monitoring, identifying high-risk situations, coping strategies, cognitive behavioural therapy and intra-treatment support. All patients attending the UET are referred by a doctor. Individual or group therapy is decided in the Smoking Cessation Service by health personnel or by patient preference. Results From 2003 to 2008 a total of 21,418 medical consultations took place. These consultations provided help to 3,920 smokers to stop smoking. The group of attended smokers consisted of more or less equal numbers of men and women, their mean age was 47,83, 67% of them suffered from smoking-related disorders, 43% suffered from psychiatric co-morbidities and 21% of them suffered from other addictions. The average number of cigarettes smoked daily was 28, and they suffered from high nicotine dependence (over 77% smoked their first cigarette within 30 min after waking up). The vast majority of patients seen (97.6%) received both pharmacological treatment and psychotherapy, either individually or in groups. Only 2.4% of them received just psychological treatmet. Treatment was individual for 87% of the patients and by group for the rest. Efficacy data at 6th, 12th, 36th, and 57th months follow-up were 58,5%, 54,9%, 42% and 35%, respectevely. >>
treatment outpatient general population Spain 2
Title: Euregio-Konekt. Violence Prevention in the Euregio Maas-Rhein
Summary: A violence prevention project for schools in the German speaking community in Belgium. >>
prevention process evaluation school, community adults, children/young people Belgium 1
Title: Programme to Prevent Tobacco Addiction in the Murcia Town Hall: Less Smoke, More Life, for a Healthy Town Hall for All
Summary: In 1998 the Municipal Government of Murcia initiated a programme against tobacco addiction consisting of 2 components, a health promotion and education unit for all municipal workers and a unit for employees who wish to quit smoking. As a result of the project, tobacco addiction among Murcia Town Hall employees is estimated to have declined by 15-20% >>
prevention outcome evaluation, process evaluation adults Spain 1
Title: Community Smoking Cessation Programme, With Reimbursement Of Drug Treatment Contingent Upon Success
Summary: The purpose of this Catalonian project was to reduce tobacco addiction among the general population and provide an incentive for cessation in the form of reimbursement of the costs of the drug treatment for participants who were abstinent six months after the intervention. >>
treatment outcome evaluation, process evaluation adults, children/young people Spain 1

Displaying results 1–10 of 15 where Substances addressed by the intervention is Tobacco

<< previous next >>

Survey

Dear visitor,

We're currently conducting a short survey of this resource (EDDRA: Exchange on Drug Demand Reduction Action). The survey will take no more than 2 minutes and we would be really grateful for your contribution.

No, thanks — maybe some other time

Yes, I'll take the survey!

Many thanks,

The EDDRA team

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Friday, 20 January 2012